Veracyte to acquire Allegro Diagnostics - MarketLine Financial Deals

Veracyte to acquire Allegro Diagnostics

Veracyte to acquire Allegro Diagnostics - MarketLine Financial Deals
Veracyte to acquire Allegro Diagnostics
Published Sep 04, 2014
3 pages — Published Sep 04, 2014
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Veracyte, Inc., a molecular diagnostics company, has agreed to acquire Allegro Diagnostics Corp., a company engaged in developing genomic tests to improve the preoperative diagnosis of lung cancer

  
Source:
Document ID
MA150748_140925
Country
Ticker
VCYT=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Veracyte to acquire Allegro Diagnostics" Sep 04, 2014. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Veracyte-to-acquire-Allegro-Diagnostics-2052-106223>
  
APA:
MarketLine Financial Deals. (2014). Veracyte to acquire Allegro Diagnostics Sep 04, 2014. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Veracyte-to-acquire-Allegro-Diagnostics-2052-106223>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.